Correction: Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity

Silvia Roscales; Nicole Bechmann; Daniel Holger Weiss; Martin Köckerling; Jens Pietzsch; Torsten Kniess

doi:10.1039/C8MD90011F

This website uses cookies to give you the best user experience. If you continue without changing your settings we'll assume you are happy to receive all RSC cookies. You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions are also obtainable from the privacy link at the bottom of any RSC page.

Lite Version|Standard version

Home > MedChemComm > Correction: Novel valde...

Correction: Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity

Silvia Roscales, Nicole Bechmann, Daniel Holger Weiss, Martin Köckerling, Jens Pietzsch and Torsten Kniess
Med. Chem. Commun., 2018,9, 591-592
DOI: 10.1039/C8MD90011F, Correction

Open Access Learn more..

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.

Download

PDF

Rich HTML

Abstract | Cited by

Correction for ‘Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity’ by Silvia Roscales et al., Med. Chem. Commun., 2018, DOI: 10.1039/c7md00575j.

Page: ^ Top

Terms & Conditions | Privacy and Cookies